Senciticity:96.4%(95%CI:90.8%-98.2%)
Specificity:99.8%(95%CI:94.4%-99.9%)
Intended use
This product is used for in vitro qualitative detection of the SARS-CoV-2 antigen in human nasal swab specimen. It is intended for personal use by untrained layman as a rapid test method for novel coronavirus infection.
Test principle
This product uses the double antibody sandwich method to detect the SARS-CoV-2 N protein. When the sample contains the coronavirus antigen, both the test line (C) and the control line (T) will appear, and the result will be positive. When the sample does not contain the coronavirus antigen or no coronavirus antigen is detected, the test line (T) will not appear, only control line (C) will appear.
Product advances
1.Pre-filled buffer solution, easier operation.
2.Passed the PEI evaluation.
3.Room temperature storage.
4.No need instrument, get results within 15 minutes.
5.Identify acute or early infection.
6.No reduction in sensitivity test against the Alpha, Beta, Delta, Gamma, Lambda, Omicron variant and so on.
Materials and Components
1.Test Device
2.Instruction
3.Antigen Extraction Tube with Extraction Reagent
4.Collection Bag
5.Sterilized Swab
6.Timer(Materials required but not provided)
Product Information
Specification | 1pcs/box,5pcs/box,25pcs/box |
Specimen | Human Anterior Nasal Swab |
Storage | 4-30℃ |
Test Procedure
Allow test device extraction reagent and specimens to equilibrate to room temperature(15 ~ 30 ℃) prior to testing.Please keep the temperature at 15 ~ 30 ℃ and the humidity at20%-80% during the whole test.
1.Specimen Collection
(1)Remove the sterilized swab from the packaging.
(2)Roll the swab firmly around the inside of the nostril, making 5 complete circles. Using the same swab, repeat this process for the other nostril.
2.Testing
3.Test Results
Read result at 15 minutes.Do not read results after 30minutes.
Clinical Performance
There were 520 cases overall in the study, including 110 positive samples and 410 negative samples. Statistics of nasal swab test results were as follows:
Reference RT-PCR Assay |
95% Wilson Score CI |
|||||||
LCI |
UCI |
|||||||
DEEPBLUE SARS-CoV-2 Ag Test |
|
POS |
NEG |
Total |
PPA |
96.4% |
90.8% |
98.2% |
POS |
106 |
1 |
107 |
NPA |
99.8% |
94.4% |
99.9% |
|
NEG |
4 |
409 |
413 |
PPV |
99.1% |
93.7% |
99.8% |
|
TOTAL |
110 |
410 |
520 |
NPV |
99.0% |
93.5% |
99.7% |
Sensitivity: 96.4% (95% CI: 90.8% - 98.2%)
Specificity: 99.8% (95% CI: 94.4% - 99.9%)